Tax peptide-pulsed dendritic cell vaccine

N/A

Report date: 2022/12/27 09:22:55

Base Information

Drug NameTax peptide-pulsed dendritic cell vaccine

Drug Alias NameATL-DC-101

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsLymphoma, T-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesTokyo Medical And Dental University

China Registration ClassN/A

Develop Information

Active CompaniesTottori University Kyoto University Tokyo Medical And Dental University +[5]

Inactive CompaniesN/A

Active IndicationsLymphoma, T-Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A